showed that CD8+FOXP3+ T cells are immunosuppressive, but, their inhibitor function could be altered using Toll‐Like Receptor (TLR)‐8 signaling40, 45 suggesting this could be utilized by immunotherapeutic strategies in cancer.40, 45. This evidence concerns the gene TLR8 and cancer.